InvestWiser

Simris Alg AB (publ)

SIMRIS-BNasdaq StockholmHealthcareMarket value 130 m SEK
0.10SEK +7.9%
last day · Price as of 18 November 2026

The answer first

Does Simris Alg beat the market?

No, Simris Alg has not beaten the market over the last year.

Simris Alg−18.0%Stockholm (OMXSGI)+18.7%
  • The ranking · Quality, value and trend combined

    Better than 10% of Nordic stocks

    • Quality16
    • Value1
    • Trend64

    No. 162 of 195 in healthcare

Max for seven days

Follow Simris Alg with Aurora

Aurora lets you know at the next report. No card.

Both with dividends. Figures as of 18 November 2026. General analysis, not personal advice.

Follow your thesis

Follow your thesis on Simris Alg

From today, at a price of 0.10 SEK. Write why you follow Simris Alg, and choose what Aurora should tell you about.

What should Aurora follow?

Free, no card. The mission is ready when your account is.

Aurora tells you that something happened. What you do is your choice.

Ask Aurora about Simris Alg

Your first answer is free, no account needed.

Do you own Simris Alg, or are you thinking about it?

See it next to the rest of your portfolio, or build your first one with Simris Alg and a few more. Free, no card.

Past year against the exchange and Super Stock
Simris Alg−11.9%Stockholm (OMXSGI)+18.7%Super Stock+45.9%
14 November 202518 November 2026
All start at 0 % a year ago, with dividends. Super Stock is our model portfolio: the 20 highest-ranked Nordic stocks on quality, value and trend.

In short

  • Simris Alg has fallen 18.0% over the past year, including dividends.
  • Overall, Simris Alg ranks better than 10% of Nordic stocks on quality, value and trend.
  • The largest fall over the past three years was 93.6%. The price is 99.0% below its peak now.

Quality, value and trend

Quality is about the company, value about the price you pay, and trend about the share price. Each pillar shows the numbers it is built on.

10

Quality, value and trend together. Better than 10% of Nordic stocks.

No. 162 of 195 in healthcare

Quality16
The company · Fundamentals: the accounts

Low Weaker accounts than most: low profitability, high debt or uneven results.

No. 175 of 196 in healthcareTypical in healthcare: 64Typical in the Nordics: 50

  • Debt to equityBorrowings divided by equity0.00
  • Asset turnoverSales divided by everything the company owns0.01
  • Return on equityProfit divided by equity−492.2%
  • Cash conversionOperating cash flow divided by profit–

The ranking is built on equity ratio, ROA and how steadily profit grows.

Value1
The price · Valuation: the multiples

Low High price: buyers pay a lot today, often because they expect growth.

No. 191 of 197 in healthcareTypical in healthcare: 21Typical in the Nordics: 50

  • P/BPrice divided by equity23.0
  • P/SPrice divided by sales104.4
  • P/EPrice divided by earningsnegative earnings
  • P/CFPrice divided by operating cash flownegative earnings

The ranking is built on P/E, P/B and P/S.

Trend64
The share price · Technical: the price trend

Medium The share price has moved about like most stocks over the last year.

No. 57 of 198 in healthcareTypical in healthcare: 34Typical in the Nordics: 50

  • 3 months−3.7%
  • 6 months+11.0%
  • 9 months+21.5%
  • 12 months−18.0%

The ranking is built on 3, 6 and 12–1 months.

Return and risk

1 month
−25.2%
3 years, per year
−31.9%
5 years, per year
−28.7%
10 years, per year
−35.3%
Largest fall, 3 years
−93.6%
From a peak to the bottom
From the peak now
−99.0%
How far the price is from the peak
Volatility, 1 year
164.9%
How much the price swings over a year
Beta, 1 year
−0.08
How much the price moves when the market moves

Return with dividends reinvested.

About Simris Alg

Simris Alg AB (publ) is a company in healthcare, listed on Nasdaq Stockholm. The share trades in SEK. It has around 6 employees.

Simris Group AB (PUBL), a biotechnology company, develops antibody-drug conjugate (ADC) payloads in Sweden and internationally. The company develops, manufactures, and sells bioactive substances from cultured microalgae and cyanobacteria. It also offers cosmetics and skincare products; biopharmaceuticals; and dietary supplements. The company was incorporated in 2011 and is headquartered in Hammenhög, Sweden.

See the full analysis of Simris Alg.

The accounts, dividends, 40 years of charts and the comparison with other stocks are in the app.

Free forever · No card

Other healthcare stocks on Nasdaq Stockholm

Explore the stock market